参考文献/References:
[1] Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system[J]. J Biol Chem, 1987, 262:4429~4432.
[2] Madon J, Blum HE. Receptor-mediated delivery of hepatitis Bvirus DNA and antisense oligodeoxynucleotides to avian liver cells[J].Hepatology, 1996, 24:474~481.
[3] Sugano M, Makino N. Changes in plasma lipoprotein cholesterol level by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits[J]. J Biol Chem, 1996, 271:19080~19083.
[4] Sugano M, Makino N, Sawada S, et al. Effect of antisense oligodeoxynucleotides against cholestryl ester tansfer protein on the development of atherosclerosis in cholesterol-fed rabbits[J]. J Biol Chem, 1998, 273:5033~5036.
[5] Wagner E, Zenke M, Cotton M, et al. Teansferrin-polycation conjugates as carriers for DNA uptake into cells[J]. Proc Natl Acad Sci USA, 1990, 87:3410~3414.
[6] Citro G, Perrotti D, Cucco C, et al. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antiserse oligodeoxynucleotides[J].Proc Natl Acad Sci USA, 1992, 89:7031~7036.
[7] Citro G, Ginobbi P, Candiloro A, et al. Chemical modification of ligands for cell receptors to introduce foreign compounds into the cells[J]. Dis Colon Rectum, 1994, 37(suppl):s127~s132.
[8] Reddy JA, Low PS. Folate-mediated targeting of therapeutic andimaging agents to cancers[J]. Crit Rev Ther Carrier Syst, 1998, 15:587~627.
[9] Ginobbi P, Geiser TA, Ombres D, et al. Folic acid-polylysine carrier improves efficacy of c-myc antisense[J]. Anticancer Res, 1997, 17(1A):29~35.
[10] Wang S, Lee RJ, Cauchon G, et al. Delivery of antisense oligodeoxynucleotids against the human epidermal growth factor receptor into cultured KB cell with liposemes conjugated to folate via polyethylene glycol[J]. Proc Natl Acad Sci U SA, 1995, 92:3318~3312.
[11] Cristiano RJ, Roth JA. Epidermal growth factor mediated DNA delivery into lung cells via the epidermal growth factor receptor[J]. Cancer Gene Ther, 1996, 3(1):4~10.
[12] Liang WW, Shi X, Deshpande D, et al. Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis[J]. Biophys Acta,1996, 1279(2):227~234.
[13] Rojanasakul Y, Weissman DN, Shi X, et al. Antisense inhibition of silica-induced tumor necrosis factor in alveolar macrophages[J]. J Biol Chem, 1997, 272(2):3910~3914.
[14] Miller N, Vile R. Targeted vectors for gene therapy[J]. Faseb J, 1995, 9:190~199.
相似文献/References:
[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[3]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[4]杨洋,樊赛军.LXXLL模体在雌激素受体信号通路中的作用及应用价值[J].国际放射医学核医学杂志,2014,38(1):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
Yang Yang,Fan Saijun.Role of LXXLL motif in modulation of estrogen receptor signaling and its potential application[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
[5]白庆双,李宁,方佩华,等.人血清TRAb酶联免疫吸附试验检测在甲状腺疾病患者中的临床应用[J].国际放射医学核医学杂志,2014,38(2):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
Bai Qingshuang,Li Ning,Fang Peihua,et al.The clinical application of human serum level of the TRAb measured by enzyme-linked immunosorbent assay in patients with thyroid diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
[6]李丽,赵长久,田国梅.CXC型趋化因子受体4及其分子显像剂在肿瘤方面的研究进展[J].国际放射医学核医学杂志,2014,38(3):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
Li Li,Zhao Changjiu,Tian Guomei.Research progress of CXC chemokine receptor type 4 and molecular imaging in tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
[7]周晓靓,王浩,施培基,等.表皮生长因子受体-酪氨酸激酶肿瘤分子显像剂的研究进展[J].国际放射医学核医学杂志,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
ZHOU Xiao-liang,WANG Hao,SHI Pei-ji,et al.The developme nt of epidermal growth factor receptor molecular imaging in cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
[8]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[9]袁杰,刘兴党,韩梅.SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用[J].国际放射医学核医学杂志,2013,37(1):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
YUAN Jie,LIU Xing-dang,HAN Mei.Neuroreceptor and its transporters imaging by PET and SPECT in heroin addiction[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
[10]鲍伟奇,邱春,管一晖.γ-氨基丁酸A型-苯二氮革受体显像剂在神经系统疾病中的应用[J].国际放射医学核医学杂志,2012,36(1):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]
BAO Wei-qi,QIU Chun,GUAN Yi-hui.Application of gamma-aminobutyric acid type A-benzodiazepine receptor imaging for study of neuropsychiatric disorders[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]